| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.166.2.973 |
| P698 | PubMed publication ID | 11145675 |
| P2093 | author name string | M H Sayegh | |
| E Palmer | |||
| L A Turka | |||
| A D Wells | |||
| P B Langmuir | |||
| E J Suchin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 973-981 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question | |
| P478 | volume | 166 |
| Q38694588 | A New Window into the Human Alloresponse |
| Q36945001 | A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection |
| Q36797508 | A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection |
| Q51969757 | A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. |
| Q103829411 | A post-preservation vascular flush removes significant populations of donor leukocytes prior to lung transplantation |
| Q43538607 | A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro |
| Q28538078 | Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses |
| Q43606110 | Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells |
| Q47917089 | AhR activation increases IL-2 production by alloreactive CD4+ T cells initiating the differentiation of mucosal-homing Tim3+ Lag3+ Tr1 cells |
| Q50526246 | Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells. |
| Q52728730 | Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype. |
| Q80309072 | Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity |
| Q73267376 | Allograft rejection in a new allospecific CD4+ TCR transgenic mouse |
| Q50936985 | Alloimmune T cells in transplantation. |
| Q34080563 | Alloimmunity and autoimmunity in chronic rejection |
| Q37006610 | Allopeptides and the alloimmune response |
| Q37324329 | Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. |
| Q42613015 | Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes |
| Q52716672 | Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α. |
| Q51591900 | Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia. |
| Q35000627 | Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells. |
| Q37769912 | Alloreactivity from human viral specific memory T-cells |
| Q28067365 | Allorecognition by T Lymphocytes and Allograft Rejection |
| Q34382303 | Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation |
| Q33731831 | An affinity/avidity model of peripheral T cell regulation |
| Q34562561 | Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. |
| Q38981557 | Antigen Presentation in Transplantation |
| Q36229698 | Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation |
| Q35129735 | Apoptosis and transplantation tolerance. |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q37603816 | Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy |
| Q34657615 | B cells and B cell products-helping to restore cellular immunity? |
| Q34389662 | B7-H3 promotes acute and chronic allograft rejection |
| Q34144168 | Bacterial probiotic modulation of dendritic cells |
| Q26749553 | Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation |
| Q34146648 | Both positive and negative effects on immune responses by expression of a second class II MHC molecule. |
| Q42087892 | Both rejection and tolerance of allografts can occur in the absence of secondary lymphoid tissues |
| Q47766245 | CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts |
| Q35940361 | CD8 memory T cells: cross-reactivity and heterologous immunity. |
| Q34275442 | Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs |
| Q36011368 | Cellular and molecular targeting for nanotherapeutics in transplantation tolerance |
| Q35583494 | Cell‐cycle regulation of T‐cell responses – novel approaches to the control of alloimmunity |
| Q38681685 | Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity |
| Q80592798 | Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-gamma and IL-10 producing T cells |
| Q35730793 | Clinical islet transplantation: advances and immunological challenges |
| Q37843801 | Clinical transplantation tolerance |
| Q37610904 | Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain |
| Q37396882 | Combining Theoretical and Experimental Techniques to Study Murine Heart Transplant Rejection |
| Q84300301 | Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation |
| Q35745238 | Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus |
| Q36585241 | Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity? |
| Q26752289 | Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation |
| Q37661374 | Cross-immune tolerance: conception and its potential significance on transplantation tolerance |
| Q36456980 | Cyclin-dependent kinase 2 controls peripheral immune tolerance |
| Q36769222 | Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance |
| Q46961808 | Deacetylase inhibition promotes the generation and function of regulatory T cells. |
| Q38335413 | Dendritic cells and innate immunity in kidney transplantation |
| Q33785850 | Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay |
| Q39956641 | Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment |
| Q37232364 | Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants |
| Q38515353 | Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance. |
| Q36889770 | Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice |
| Q37482027 | Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation |
| Q41658209 | Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts |
| Q37474216 | Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction |
| Q82651284 | Donor-strain-derived immature dendritic cell pre-treatment induced hyporesponsiveness against allogeneic antigens |
| Q34111446 | Dual receptor T cells extend the immune repertoire for foreign antigens. |
| Q37383856 | Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease |
| Q44204267 | Dual-specific T cells combine proliferation and antitumor activity |
| Q79965171 | Effect of interleukin-15 on alloreactivity in umbilical cord blood |
| Q90366876 | Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression |
| Q37317873 | Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin |
| Q39366464 | Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans |
| Q34450109 | Evolving concepts of specificity in immune reactions |
| Q79116877 | Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation |
| Q44625716 | Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects |
| Q33867766 | Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses |
| Q44620458 | Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance |
| Q34718383 | Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise |
| Q64075115 | Foxp3 Regulatory and Conventional CD4 T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells |
| Q35160821 | Generation of human alloantigen-specific T cells from peripheral blood. |
| Q36765387 | Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis |
| Q37341025 | HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies |
| Q37486032 | Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model |
| Q35095576 | Heterologous immunity provides a potent barrier to transplantation tolerance |
| Q35583521 | Heterologous immunity: an overlooked barrier to tolerance |
| Q92863309 | High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells |
| Q41830723 | High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade |
| Q33731951 | Homeostatic proliferation is a barrier to transplantation tolerance |
| Q40176893 | How an alloreactive T-cell receptor achieves peptide and MHC specificity |
| Q33707337 | Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice |
| Q38611225 | Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity |
| Q33577374 | Human allograft rejection in humanized mice: a historical perspective |
| Q21245470 | Human embryonic stem cells hemangioblast express HLA-antigens |
| Q36001183 | IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation |
| Q42129294 | Immune parameters to consider when choosing T-cell receptors for therapy |
| Q33940662 | Immune surveillance of the maternal/fetal interface: controversies and implications |
| Q35558501 | Immunobiology of acute graft-versus-host disease |
| Q53616359 | Immunoglobulin promotes the diversity and the function of T cells. |
| Q35583546 | Immunologic monitoring. |
| Q33996931 | Immunosuppression for lung transplantation |
| Q89455203 | Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques |
| Q37183450 | Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts. |
| Q92217085 | In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long-Term Hematopoietic Engraftment |
| Q37328591 | In vitro assays of allosensitization |
| Q42146101 | In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease |
| Q46054318 | Inability to induce tolerance through direct antigen presentation |
| Q35366857 | Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation. |
| Q41351550 | Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein |
| Q39440909 | Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms. |
| Q35087194 | Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation |
| Q90389299 | Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules |
| Q35917157 | Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. |
| Q34722171 | Insights into the specificity and function of (allo)antigen-reactive T cells |
| Q40220156 | Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide |
| Q38123309 | Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection |
| Q41890374 | Intervention of PKC-θ as an immunosuppressive regimen |
| Q84233261 | Inverse relationship between dendritic cell CCR9 expression and maturation state |
| Q27321721 | Ionizing radiation selectively reduces skin regulatory T cells and alters immune function |
| Q33950808 | Lessons from cardiac transplantation in infancy |
| Q36369536 | Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells |
| Q34519955 | Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice |
| Q37328528 | Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice |
| Q33614049 | Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry |
| Q38272861 | Memory T Cells in Transplantation |
| Q36528984 | Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity |
| Q38725481 | Mesenchymal stromal cells in renal transplantation: opportunities and challenges. |
| Q26797506 | Modern approaches to HLA-haploidentical blood or marrow transplantation |
| Q83937463 | Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study |
| Q35573970 | Myocardial Tissue Engineering and Regeneration as a Therapeutic Alternative to Transplantation |
| Q30501692 | NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity |
| Q46813563 | NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice |
| Q34506806 | Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation |
| Q33936014 | New insights into the functions of B cells |
| Q34398610 | New tools to trace populations of inflammatory cells in the CNS. |
| Q77719695 | Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition |
| Q34568892 | Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. |
| Q37662989 | Old game, new players: Linking classical theories to new trends in transplant immunology |
| Q41257879 | Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy |
| Q36152685 | Organ transplantation--how much of the promise has been realized? |
| Q34597955 | PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue |
| Q37798037 | PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection |
| Q35634710 | Pathophysiology of acute graft-versus-host disease |
| Q37236992 | Pathways of major histocompatibility complex allorecognition. |
| Q41510934 | Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys |
| Q37305376 | Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses |
| Q35107989 | Platelets contribute to allograft rejection through glutamate receptor signaling |
| Q30502451 | Polarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway |
| Q98466664 | Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients |
| Q46670813 | Preferential priming of alloreactive T cells with indirect reactivity |
| Q40259157 | Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation. |
| Q34382257 | Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free liver transplantation. |
| Q36866534 | Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection |
| Q58792336 | Quantifying size and diversity of the human T cell alloresponse |
| Q35615865 | Rapid quantification of naive alloreactive T cells by TNF-alpha production and correlation with allograft rejection in mice |
| Q38187176 | Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy |
| Q35116592 | Regulation of T cell differentiation and alloimmunity by the cyclin-dependent kinase inhibitor p18ink4c |
| Q34975720 | Regulation of murine dendritic cell immune responses by Helicobacter felis antigen |
| Q39823591 | Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival |
| Q39957163 | Regulatory T cells in transplantation: what we know and what we do not know |
| Q38027504 | Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. |
| Q35044185 | Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts |
| Q33338486 | Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survival |
| Q37286424 | Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine |
| Q38025804 | Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications |
| Q35893636 | Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts |
| Q37619093 | Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ |
| Q64122265 | Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease |
| Q35671669 | Routes to transplant tolerance versus rejection; the role of cytokines. |
| Q37002818 | Specificity of T-cell alloreactivity |
| Q27646543 | Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens |
| Q39104486 | Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. |
| Q37069742 | Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses |
| Q35583489 | Surface T‐cell antigen receptor expression and availability for long‐term antigenic signaling |
| Q34241136 | T cell death and transplantation tolerance. |
| Q33987835 | T regulatory cells and transplantation tolerance |
| Q35129543 | T-Cell Allorecognition and Transplant Rejection: A Summary and Update |
| Q35803977 | T-cell activation and transplantation tolerance |
| Q34360502 | TCR usage in naive and committed alloreactive cells: implications for the understanding of TCR biases in transplantation |
| Q47381937 | TNFR2: The new Treg switch? |
| Q39737971 | Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. |
| Q26776548 | The Timing of T Cell Priming and Cycling |
| Q34269276 | The allogeneic response and tumor immunity |
| Q35583506 | The balance of deletion and regulation in allograft tolerance. |
| Q35058547 | The complementary roles of deletion and regulation in transplantation tolerance |
| Q44408026 | The effect of exposing murine splenocytes to UVB light, psoralen plus UVA light, or gamma-irradiation on in vitro and in vivo immune responses |
| Q73508392 | The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model |
| Q37390250 | The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease |
| Q37607455 | The immunological monitoring of kidney and liver transplants in adult and pediatric recipients |
| Q34650563 | The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein |
| Q37896918 | The innate immune system in transplantation. |
| Q40492615 | The proliferation inhibitory proteins p27(Kip1) and retinoblastoma are involved in the control of equine lymphocyte proliferation. |
| Q78339271 | The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant |
| Q35893645 | The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials |
| Q39785791 | The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. |
| Q37551442 | Theories and quantification of thymic selection |
| Q73676784 | Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cells |
| Q40003132 | Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat. |
| Q34110593 | Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains |
| Q35893656 | Tolerance induction in clinical transplantation |
| Q37800529 | Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment |
| Q83956260 | Towards the identification of biomarkers of transplantation tolerance |
| Q33368763 | Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution |
| Q42039485 | Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. |
| Q61805676 | Transient increase of activated regulatory T cells early after kidney transplantation |
| Q40519556 | Transplant tolerance: a new role for IL-34. |
| Q35951541 | Tregs and transplantation tolerance |
Search more.